Rapid Microbiology Testing Market Worth $5.09 Billion by 2023

PUNE, India, September 12, 2018 /PRNewswire/ --

According to a new market research report "Rapid Microbiology Testing Market by Method (Growth, Viability), Product (Automated Microbial Identification & AST System, PCR, Reagent), Application (Clinical Diagnosis, Environmental), End User (Labs, Hospitals, Industry) - Global Forecast to 2023", published by MarketsandMarkets™, the global market is expected to reach USD 5.09 billion by 2023 from USD 3.45 billion in 2018, at a CAGR of 8.1%.

     (Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg )

For more Insights on this report, Speak to Our Analyst: 

" https://www.marketsandmarkets.com/speaktoanalyst.asp?id=31548521

The major factors driving the growth of the Rapid Microbiology Testing Market include the rising prevalence of infectious diseases; ongoing technological advancements; increasing food safety concerns; and increased funding, research grants, & public-private investments.

Browse in-depth TOC on "Rapid Microbiology Testing Market"

90 - Tables  

42 - Figures  

188 - Pages    

The instruments segment is expected to account for the largest share of the products market in 2018 

On the basis of product, the Rapid Microbiology Testing Market is segmented into instruments, reagents & kits, and consumables. The instruments segment is further categorized into automated ID/AST systems, mass spectrometers, PCR systems, bioluminescence- and fluorescence-based detection systems, cytometers, active air samplers, and other instruments. The automated microbial ID/AST systems segment is expected to command the largest share of the global Rapid Microbiology Testing Market in 2018. This is primarily due to the ability of these systems to produce rapid, accurate, reliable, and cost-effective results.

Growth-based rapid microbiology testing is expected to account for the largest share of the market, by method, in 2018 

Based on method, the global Rapid Microbiology Testing Market is classified into segments growth-based, viability-based, cellular component-based, nucleic acid-based, and other rapid microbiology testing methods. The growth-based segment is expected to account for the largest share of the Rapid Microbiology Testing Market in 2018. The large share of this segment can be attributed to factors such as the ease of processing (this method uses conventional liquid or agar media), the limited requirement of skilled professionals, and supportive government regulations.

https://www.marketsandmarkets.com/Market-Reports/rapid-microbiology-testing-market-31548521.html

North America is expected to dominate the Rapid Microbiology Testing Market during the forecast period.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the global Rapid Microbiology Testing Market during the forecast period (2018-2023). The large share of this market can be attributed to the growing technological advancements in the field of rapid microbial testing, rising incidence of infectious diseases, and growing food safety concerns. In addition, the region has supportive government initiatives that help create awareness and promote the adoption of advanced microbial testing devices among key end users, thereby propelling the growth of the Rapid Microbiology Testing Market in North America.

The major players operating in the Rapid Microbiology Testing Market include bioMérieux SA (France), Danaher Corporation (US), and Becton, Dickinson and Company (US), among others.

Request for PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=31548521

About MarketsandMarkets™  

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/rapid-microbiology-testing-market.asp

SOURCE MarketsandMarkets